ChartMill assigns a Buy % Consensus number of 83% to COCP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-01-24 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-07 | HC Wainwright & Co. | Maintains | Buy |
8 analysts have analysed COCP and the average price target is 8.16 USD. This implies a price increase of 692.23% is expected in the next year compared to the current price of 1.03.
The consensus rating for COCRYSTAL PHARMA INC (COCP) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.